4.6 Article

Downregulation of circ_0132266 in chronic lymphocytic leukemia promoted cell viability through miR-337-3p/PML axis

Journal

AGING-US
Volume 11, Issue 11, Pages 3561-3573

Publisher

IMPACT JOURNALS LLC
DOI: 10.18632/aging.101997

Keywords

circular RNA; circRNAs; chronic lymphocytic leukemia; CLL; miR-337-3p; PML; ceRNA

Funding

  1. National Natural Science Foundation of China [81700155, 81600162, 81370657, 81470328, 81600130, 81770166, 81720108002, 81700193]
  2. Jiangsu Province's Medical Elite Programme [ZDRCA2016022]
  3. Jiangsu Provincial Special Program of Medical Science [BE2017751]
  4. National Science and Technology Major Project [2018ZX09734-007]

Ask authors/readers for more resources

Circular RNAs (circRNAs) have recently been reported to play crucial roles in various regulatory processes and involved in cancer onset and progression. However, the potential mechanism of circRNAs in chronic lymphocytic leukemia (CLL) remains largely unknown. Here, we observed hsa_circ_0132266 (circ_0132266), a circRNA significantly decreased in the peripheral blood mononuclear cells (PBMCs) of CLL patients compared with healthy donors, could act as an endogenous sponge of hsa-miR-337-3p (miR-337-3p) and regulate its activity, which resulted in a downstream change of target-gene PML and a consequent influence on cell viability. Taken together, our data indicated the regulatory mechanism of circ_0132266 in CLL progression through circ_0132266/miR-337-3p/PML axis, suggesting that it may serve as a biomarker as well as an exploitable therapeutic target for CLL.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available